Objective To assess the accuracy of European organization of research and treatment of cancer(EORTC) risk tables in predicting the prognosis of patients with non-muscle-invasive bladder cancer(NMIBC) treated in our hospital.Methods The clinical data of 236 patients with NMIBC treated in our hospital,from January 2002 to December 2007,were analyzed retrospectively.All of the patients underwent transurethral resection of the cancer,and received postoperative intravesical chemotherapy.A follow-up of(mean) 16-78(41) months was conducted.By using the EORTC,all the patients were scored and divided into several groups based on different total scores.One-year and five-year recurrence rate and progression rate were calculated and compared with the results obtained by the EORTC risk tables.Results The results of calculation were as follows: the one-year recurrenence rate in patients scored 0,1-4,5-9,and 10-17 points was 11.1%,21.2%,35.6% and 55.2%;five-year recurrence rate was 25.9%,43.9%,58.6% and 75.9%,respectively.The one-year progression rate in those scored 0,2-6,7-13,and 14-23 was 0,1.2%,5.2%,and 15.4%;five-year recurrence rate was 0%,9.4%,13.8%,and 50.0%,respectively.Compared with EORTC risk tables,no significant statistical difference was indicated(P0.05).Conclusion EORTC risk tables is worth recommending in patients accurately grouped according to risk possibility of recurrence and progression.

>肾脏原发性恶性纤维组织细胞瘤(malignant fibrous histiocytoma,MFH)临床罕见,患者生存期短,死亡率高。2008年至2010年我院收治2例,现报告如下。例1,女,55岁。因右侧腰痛2年,血尿3 d于2008年11月入院。查体及实验室检查未见异常。B超检查:右肾上极6 cm×5 cm低回声团块,边缘不规则。增强CT检查示右肾上极较大混杂密度肿块影,不均匀强化,边界欠清,腹

目的 探讨肾脏神经鞘瘤的临床特点.方法 回顾性分析2011年3月我院泌尿外科诊治的1例肾脏神经鞘瘤患者的临床资料,结合国内外有关文献报道分析肾脏神经鞘瘤的诊断和治疗特点.结果 该患者充分术前准备后行手术完整切除肿瘤,术后病理证实均为良性神经鞘瘤,随访未发现复发.结论 肾脏神经鞘瘤罕见,诊断困难,影像学检查无特异性,确诊依靠病理检查,理想的治疗方法是通过外科手术完整切除肿瘤,其预后良好,早期复发率低.